iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are presently covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $135.00.
Several equities research analysts have weighed in on the company. Truist Financial upped their target price on iRhythm Technologies from $115.00 to $133.00 and gave the stock a “buy” rating in a report on Friday, December 22nd. Needham & Company LLC upped their price objective on iRhythm Technologies from $108.00 to $136.00 and gave the stock a “buy” rating in a research note on Monday, January 8th. Citigroup upgraded iRhythm Technologies from a “neutral” rating to a “buy” rating and set a $110.00 price objective for the company in a research note on Monday, December 11th. StockNews.com cut iRhythm Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th. Finally, Morgan Stanley decreased their price objective on iRhythm Technologies from $149.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday, October 11th.
iRhythm Technologies Price Performance
iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last issued its earnings results on Thursday, November 2nd. The company reported ($0.89) earnings per share for the quarter, missing the consensus estimate of ($0.65) by ($0.24). iRhythm Technologies had a negative return on equity of 46.35% and a negative net margin of 22.19%. The firm had revenue of $124.60 million during the quarter, compared to analysts’ expectations of $122.46 million. On average, analysts predict that iRhythm Technologies will post -3.38 EPS for the current fiscal year.
Insider Buying and Selling at iRhythm Technologies
In other iRhythm Technologies news, EVP Daniel G. Wilson sold 7,218 shares of the stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $103.31, for a total value of $745,691.58. Following the completion of the sale, the executive vice president now directly owns 26,629 shares in the company, valued at $2,751,041.99. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.43% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. Headlands Technologies LLC acquired a new position in shares of iRhythm Technologies in the second quarter valued at about $177,000. Mackenzie Financial Corp increased its holdings in shares of iRhythm Technologies by 3.4% in the third quarter. Mackenzie Financial Corp now owns 1,262,179 shares of the company’s stock valued at $111,425,000 after purchasing an additional 41,052 shares during the period. TD Asset Management Inc increased its holdings in shares of iRhythm Technologies by 48.4% in the third quarter. TD Asset Management Inc now owns 33,904 shares of the company’s stock valued at $3,196,000 after purchasing an additional 11,052 shares during the period. WCM Investment Management LLC acquired a new position in shares of iRhythm Technologies in the third quarter valued at about $7,779,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in iRhythm Technologies by 2.1% during the second quarter. Charles Schwab Investment Management Inc. now owns 240,711 shares of the company’s stock worth $25,111,000 after acquiring an additional 4,925 shares during the period.
About iRhythm Technologies
iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.
- Five stocks we like better than iRhythm Technologies
- Roth IRA Calculator: Calculate Your Potential Returns
- 5 best stocks to buy in a bear market
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 2 REIT stocks set to surge due to red hot data center demand
- Video Game Stocks: How to Invest in Gaming
- How and when to use LEAPS stock options
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.